BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

233 related articles for article (PubMed ID: 17544972)

  • 1. Pathogenesis of NASH: animal models.
    London RM; George J
    Clin Liver Dis; 2007 Feb; 11(1):55-74, viii. PubMed ID: 17544972
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Nonalcoholic steatohepatitis--a "new" hepatic disease].
    Grønbaek H; Eivindson MV; Hamilton-Dutoit S; Vilstrup H
    Ugeskr Laeger; 2003 Mar; 165(11):1115-8. PubMed ID: 12677985
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Nonalcoholic steatohepatitis. Three case reports].
    Eivindson MV; Hamilton-Dutoit S; Grønbaek H
    Ugeskr Laeger; 2003 Mar; 165(11):1118-20. PubMed ID: 12677986
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hepatic microcirculation in fatty liver disease.
    Farrell GC; Teoh NC; McCuskey RS
    Anat Rec (Hoboken); 2008 Jun; 291(6):684-92. PubMed ID: 18484615
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The natural history and risk factors for progression of non-alcoholic fatty liver disease and steatohepatitis.
    Miele L; Forgione A; Hernandez AP; Gabrieli ML; Vero V; Di Rocco P; Greco AV; Gasbarrini G; Gasbarrini A; Grieco A
    Eur Rev Med Pharmacol Sci; 2005; 9(5):273-7. PubMed ID: 16231589
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Animal models of NASH: getting both pathology and metabolic context right.
    Larter CZ; Yeh MM
    J Gastroenterol Hepatol; 2008 Nov; 23(11):1635-48. PubMed ID: 18752564
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [NASH -- nonalcoholic steatohepatitis].
    Blechacz B; Stremmel W
    Z Gastroenterol; 2003 Jan; 41(1):77-90. PubMed ID: 12541180
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Commonly used animal models of non-alcoholic steatohepatitis.
    Fan JG; Qiao L
    Hepatobiliary Pancreat Dis Int; 2009 Jun; 8(3):233-40. PubMed ID: 19502161
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Growth hormone reverses nonalcoholic steatohepatitis in a patient with adult growth hormone deficiency.
    Takahashi Y; Iida K; Takahashi K; Yoshioka S; Fukuoka H; Takeno R; Imanaka M; Nishizawa H; Takahashi M; Seo Y; Hayashi Y; Kondo T; Okimura Y; Kaji H; Kitazawa R; Kitazawa S; Chihara K
    Gastroenterology; 2007 Mar; 132(3):938-43. PubMed ID: 17324404
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Nonalcoholic steatohepatitis: pathogenesis and treatment].
    Park SH
    Korean J Hepatol; 2008 Mar; 14(1):12-27. PubMed ID: 18367854
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Noninvasive assessment of fibrosis in non-alcoholic fatty liver disease (NAFLD) and non-alcoholic steatohepatitis (NASH).
    Miele L; Forgione A; Gasbarrini G; Grieco A
    Transl Res; 2007 Mar; 149(3):114-25. PubMed ID: 17320797
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The establishment of a novel non-alcoholic steatohepatitis model accompanied with obesity and insulin resistance in mice.
    Cong WN; Tao RY; Tian JY; Liu GT; Ye F
    Life Sci; 2008 May; 82(19-20):983-90. PubMed ID: 18417155
    [TBL] [Abstract][Full Text] [Related]  

  • 13. New insights in the pathogenesis of non-alcoholic fatty liver disease.
    Gaemers IC; Groen AK
    Curr Opin Lipidol; 2006 Jun; 17(3):268-73. PubMed ID: 16680031
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Non-alcoholic fatty liver disease--new view].
    Raszeja-Wyszomirska J; Lawniczak M; Marlicz W; Miezyńska-Kurtycz J; Milkiewicz P
    Pol Merkur Lekarski; 2008 Jun; 24(144):568-71. PubMed ID: 18702346
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Non-alcoholic steatohepatitis in children.
    Roberts EA
    Clin Liver Dis; 2007 Feb; 11(1):155-72, x. PubMed ID: 17544977
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Serotonin mediates oxidative stress and mitochondrial toxicity in a murine model of nonalcoholic steatohepatitis.
    Nocito A; Dahm F; Jochum W; Jang JH; Georgiev P; Bader M; Renner EL; Clavien PA
    Gastroenterology; 2007 Aug; 133(2):608-18. PubMed ID: 17681180
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Review article: current management of non-alcoholic fatty liver disease and non-alcoholic steatohepatitis.
    Younossi ZM
    Aliment Pharmacol Ther; 2008 Jul; 28(1):2-12. PubMed ID: 18410557
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hepatic lipid metabolism and non-alcoholic fatty liver disease.
    Tessari P; Coracina A; Cosma A; Tiengo A
    Nutr Metab Cardiovasc Dis; 2009 May; 19(4):291-302. PubMed ID: 19359149
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Metabolic disturbances in non-alcoholic fatty liver disease.
    Byrne CD; Olufadi R; Bruce KD; Cagampang FR; Ahmed MH
    Clin Sci (Lond); 2009 Apr; 116(7):539-64. PubMed ID: 19243311
    [TBL] [Abstract][Full Text] [Related]  

  • 20. High-fat diet: a trigger of non-alcoholic steatohepatitis? Preliminary findings in obese subjects.
    Vilar L; Oliveira CP; Faintuch J; Mello ES; Nogueira MA; Santos TE; Alves VA; Carrilho FJ
    Nutrition; 2008; 24(11-12):1097-102. PubMed ID: 18640006
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.